CompletedNCT01043250
Appetite and eating behavior during antipsychotic treatment for schizophrenia
About this title
Read the official source — NCT01043250Observational studyAges 19–59South Korea
Understand this study
Who was this study for?
Listed age limits: 19 years to 59 years.
- Listed locations
- SeoulSee all locations and recruitment
Study information
Study start dateMay 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 81
- Sponsor
- Samsung Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- South Korea
- Age range
- From 19 Years to 59 Years
- Official registry ID
- NCT01043250
- Official title
Show the full official title
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients: Analysis for Three Drugs, Olanzapine, Risperidone, and Aripiprazole, Known to Induce Different Degrees of Weight Gain
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seoul
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Samsung Medical Center, a hospital or academic medical center.
Who was this study for?
Listed age limits: 19 years to 59 years.
